Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00400608 · ClinicalTrials.gov registry record · Phase 4
A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
A Phase 4 study of Asthma, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
- 3
- Study locations
NCT00400608: Completed Phase 4 study of Asthma, sponsored by GlaxoSmithKline.
NCT00400608 is a Phase 4 study of Asthma that has completed, run by GlaxoSmithKline. The registered enrollment target is 28 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00400608, a Phase 4 study of Asthma, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
- 3
- Study locations
Study Summary
Collect PK/PD data for this age group to compare ADVAIR DISKUS with ADVAIR HFA
Conditions Studied
Interventions
- DRUG ADVAIR HFA
- DRUG ADVAIR DISKUS
Study Locations (3)
California
- GSK Investigational Site - Huntington Beach
- GSK Investigational Site - Long Beach
Oregon
- GSK Investigational Site - Medford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-02 |
| Phase | Phase 4 |
What the finished NCT00400608 record still lists
NCT00400608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which ADVAIR HFA is the first listed.
NCT00400608 reports a single indexed study location in California, Oregon.
Frequently Asked Questions
What is clinical trial NCT00400608 about?
NCT00400608 is a clinical study titled "A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS". Collect PK/PD data for this age group to compare ADVAIR DISKUS with ADVAIR HFA
What is the current status of trial NCT00400608?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2006-10. Estimated completion is 2007-02.
What conditions does trial NCT00400608 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00400608?
The interventions under investigation include: ADVAIR HFA (DRUG), ADVAIR DISKUS (DRUG).
Who is sponsoring clinical trial NCT00400608?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00400608 being conducted?
This trial has 3 study locations across California, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00400608's enrollment target sits among peer trials
28 311th of 374 higher than 60 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
-
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 4
-
Viral Infection in Asthma (VIA) Study
RECRUITING · Phase 4
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
RECRUITING · Phase 4
-
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
RECRUITING · Phase 4
-
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia